Akebia Therapeutics Inc. (AKBA) rose 5.87% or 0.59 to $10.64. It is about 580972 shares traded, which is 81.4% compare to the average total volume 713689. The market cap of AKBA is $605.56 million. The year to date change is -26.99%. The 52 week price range is from $7.9 to $20.25. Price of AKBA have changed 1.62% during last week. It have changed -7.29% over last month, 1.01% over last 3 months, -32.91% over last 6 months and -27.28% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKBA is 10.19. It is -4.23% below current price. The 200-day Moving Averages for AKBA is 13.44. It is 26.32% above current price. The 52-week High is 20.25. It is 90.32% from the current price. The 52-week Low is 7.9. It is -25.75% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of AKBA is 5.2 on 2018-06-29. Short % to float is 6.56%. There are some statistics of AKBA. It is has market cap $605.56 million. The share outstanding is 56.91 million. The average volume is 713689. The revenue is 69.80M. The percent of top 15 Institution holding is 78.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKBA is -49.00%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKBA is -15.90%.